Topics On this page
|

The hard part of coming off MDMA is usually mood, not the body. Federal research summaries list withdrawal side effects among the symptoms people report as part of an MDMA-related substance use disorder, alongside continued use despite harm, tolerance and craving [1]. What no federal source publishes is an hour-by-hour MDMA withdrawal chart, and this page will not invent one.

What can be said comes from two places. MDMA is described as a lab-made drug whose effects resemble stimulants such as methamphetamine [1], and federal clinical guidance describes what stimulant withdrawal does in general [2]. Below: whether it is dangerous, what the symptoms are, what the evidence supports about duration, what makes it worse for some people, what supervision adds, and what comes after. Our page on MDMA addiction and abuse covers the drug itself.

Is MDMA Withdrawal Dangerous?

The physical answer and the psychiatric answer are different, and only one of them is reassuring.

Federal guidance is clear that stimulant withdrawal symptoms differ markedly from those seen with opioid, alcohol and sedative dependence [2]. It notes that there has been little emphasis on treating stimulant withdrawal and that consequently no medications were developed for it, because stimulant withdrawal “usually does not involve medical danger or intense patient discomfort” [2]. Against alcohol or benzodiazepines, where withdrawal can kill, that is a genuine difference.

The same passage then names the exception, and it is the reason this page exists. It describes an often overlooked but potentially lethal medical danger during stimulant withdrawal: the risk of a profound dysphoria, meaning depression and negative thoughts and feelings, that may include suicidal ideas or attempts [2]. It attributes that partly to a physiological response and partly to a person’s acute realization of the psychosocial consequences once a binge ends [2].

So the honest framing is that the danger here is mainly psychiatric. Nobody should read “no medical danger” as “safe to do alone while feeling like this”.

If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental health crisis, call or text 988.

MDMA Withdrawal Symptoms, Grouped by System

Grouping them makes the pattern easier to recognize in someone else, which is usually who is reading.

Mood and thinking carry most of it. Low mood, flattened interest, irritability and difficulty concentrating are the symptoms clinicians watch, and federal guidance singles out depression as the one that needs monitoring rather than waiting out [2]. It also records that people with stimulant addiction may experience impairment in hedonic function, which is the capacity to feel pleasure at all [2]. That is the symptom people describe as everything feeling flat.

Sleep and energy come next. Sleep is commonly disrupted in both directions, and fatigue after a period of heavy use is the body catching up rather than a complication.

Appetite and physical sensation are the third group, and they are usually the mildest. What is missing from this list matters as much as what is on it. The seizure risk and delirium that mark severe alcohol and sedative withdrawal are not the picture here [2]. Nor are the vomiting and dehydration that mark opioid withdrawal [2].

Our page on withdrawal symptoms sets out how different classes of drug compare on this.

How Long It Lasts, From the First Day to the Fourth Week

Here is the honest position. No federal source publishes an MDMA-specific day-by-day timeline, and any page that gives you one has taken it from somewhere it cannot name.

What federal guidance does give is a range for stimulant withdrawal as a class, with its hedge attached: SAMHSA’s TIP 45, citing Coffey and colleagues, says the symptoms “often disappear after several days of stimulant abstinence but can persist for 3 to 4 weeks” [2]. That is the figure this site uses, and it is stated as a range rather than a schedule because that is how the source states it.

Two qualifications belong beside it. Federal guidance notes that the period of depression in amphetamine users is more prolonged and may be more intense than in cocaine users [2], which is worth knowing here because NIDA describes amphetamines as “chemically similar” to MDMA [1]. That finding is about amphetamine users, and it is offered as context rather than transferred wholesale. And it records that where someone does not achieve abstinence, withdrawal symptoms can become a persistent component of active addiction rather than a phase that ends [2].

For scale on the other end, the acute effects of a single dose peak within 15 to 30 minutes and last an average of about three hours [1]. The gap between that and three or four weeks is the whole subject of this page.

Our guide to how long rehab takes covers the longer arc that follows.

What Makes One Person’s Withdrawal Worse Than Another’s

Four things change the picture, and none of them is the amount taken on the last occasion.

The first is what else is in it. NIDA puts it carefully: chemical analyses of drugs sold as MDMA have shown that they “may be adulterated, meaning they contain other types of drugs, perhaps without the purchaser knowing it” [1]. The hidden ingredients found have included ketamine, amphetamine, synthetic cathinones (bath salts), MDA and methamphetamine [1]. NIDA adds, in the same passage, that over the past decade illegally made opioids like fentanyl have been increasingly found in the drug supply [1]. It says they have contributed to a dramatic rise in overdose deaths in the United States [1].

So what is coming out of the system may not be what the person thought they were taking. That is the single biggest reason an assessment beats a self-diagnosis here.

If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental health crisis, call or text 988.

The second is what else is being used. Alcohol, benzodiazepines and opioids alongside MDMA change the risk completely, because withdrawal from those classes carries physical danger that stimulant withdrawal does not [2].

The third is mental health history. Where depression already existed, the dysphoria described in federal guidance lands on top of it [2].

The fourth is the setting. Whether there is somebody around for the first week is the practical variable that decides whether outpatient care is realistic.

Supervised withdrawal and what follows it, in Florida

The Recovery Village Umatilla is our campus in Umatilla, Florida, in Lake County northwest of Orlando. Its own page publishes medical detox, residential inpatient rehab, a partial hospitalization program, outpatient care, aftercare planning and inpatient mental health care.

See treatment options in Florida Verify your insurance

The Recovery Village Umatilla is part of our family of treatment centers. See the Recovery Village Umatilla campus.

Medical Detox for MDMA: What Supervision Adds

Supervision here buys monitoring and a plan, not a medication that shortens the process.

Federal guidance asks specifically that amphetamine users be monitored closely during detoxification for signs of suicidality, and treated for depression where appropriate [2]. That is the concrete thing a supervised setting adds for this class of drug: somebody whose job is to notice the mood, every day, and act on it.

If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental health crisis, call or text 988.

It also matters because of what else may be present. Where alcohol, benzodiazepines or opioids are in the picture, withdrawal management becomes a medical question rather than a psychiatric one, and our medical detox page covers what that level of care involves.

One thing supervised withdrawal is not, and federal guidance says it plainly: detoxification is not substance abuse treatment and rehabilitation, and a detox program is not designed to resolve the longstanding psychological, social and behavioral problems attached to long-term use [3]. Federal research guidance adds the consequence in one line: detoxification alone, without treatment afterwards, generally leads to a return to drug use [4].

Where care is delivered is a separate question from what it contains. Federal guidance sets out the settings, from a physician’s office through freestanding programs and partial hospitalization to acute care inpatient units, with the American Society of Addiction Medicine’s five adult detoxification levels mapped onto them [5]. Our levels of care page sets out the five main levels of treatment.

Medications and Supportive Care During MDMA Withdrawal

There is no medication for this withdrawal, and the reason is on the record rather than a gap in our knowledge.

Federal guidance states that because stimulant withdrawal usually involves neither medical danger nor intense discomfort, no medications were developed to treat it [2]. Federal research guidance puts the treatment side the same way: for addictions to drugs like stimulants, no medications are currently available to assist in treatment, so treatment consists of behavioral therapies [4].

What is treated is what is treatable. Depression during withdrawal is treated as depression, by a prescriber, where it is appropriate [2]. Sleep is managed. And where opioids or alcohol are also in play, medication-assisted treatment may be recommended for those, which is a different thing from treating the MDMA use.

No amounts, schedules or drug choices appear on this page. Those are prescribing decisions belonging to a clinician who has examined the person and knows the whole list of what they take.

Protracted Symptoms and Months One to Six

The three-to-four-week range in the evidence is about acute symptoms. It is not the whole experience, and people who expect it to be get caught out.

Federal guidance records that people with stimulant addiction may experience impairment in hedonic function, the ability to feel pleasure [2]. That is the part which outlasts the fatigue and the disturbed sleep, and it is the part most likely to be mistaken for failure in the second month.

It is also the argument for staying in treatment past the point where the acute symptoms stop. Federal research guidance holds that most people with an addiction need at least three months in treatment to significantly reduce or stop drug use, with the best outcomes at longer durations [6]. That is time in treatment overall, across levels of care, not a number of nights in a bed.

Where mood does not lift, that is a clinical question and not a character one. Say so to the program rather than waiting for month three.

Treatment After Withdrawal: Residential, PHP and IOP

The step after withdrawal is the step that decides the outcome, and it is chosen at assessment rather than picked from a list.

Residential care suits someone for whom home is where use happens, or whose mood needs daily clinical contact while it settles. A partial hospitalization program keeps close to full clinical days while the person sleeps elsewhere. An intensive outpatient program is lighter still and built to sit around work or study.

Federal research guidance asks that the plan be tailored to the person’s own drug use patterns and to their drug-related medical, mental and social problems, rather than to the substance alone [4]. For this drug that usually means the mental health side carries as much weight as the use itself.

Our inpatient rehab and outpatient rehab pages describe each level from the inside, our nationwide directory of rehab facilities lists the campuses we run, and how to get into rehab sets out the admissions sequence. Before that call, our pages on what rehab costs and on whether insurance covers rehab are worth ten minutes. Where a prescription medication is part of what is being used, our prescription drug addiction hub covers that side.

Frequently Asked Questions

How long does MDMA withdrawal last?

No federal source publishes an MDMA-specific timeline. For stimulant withdrawal as a class, federal guidance says symptoms often disappear after several days of abstinence but can persist for 3 to 4 weeks. It also notes the depression in amphetamine users is more prolonged and may be more intense, and NIDA describes amphetamines as chemically similar to MDMA.

Can I stop using MDMA on my own?

The part that needs watching is the mood. Federal guidance describes a profound dysphoria during stimulant withdrawal that may include suicidal ideas or attempts. It asks that amphetamine users be monitored closely for exactly that. Nobody should ride that out unnoticed. If someone is having thoughts of suicide, call or text 988; if they are unresponsive or having trouble breathing, call 911. Many people do stop without a program, and the physical risk is lower than with alcohol or opioids. That is context rather than the answer to whether you should do it alone.

What is the worst day of MDMA withdrawal?

There is no published worst day for this drug, and a page naming one has invented it. What federal guidance describes is a pattern rather than a peak: symptoms that often fade within several days but can run to 3 to 4 weeks, with depression the symptom most likely to persist and most in need of monitoring.

Is there medication for MDMA withdrawal?

No. Federal guidance records that no medications were developed for stimulant withdrawal, because it usually involves neither medical danger nor intense discomfort. Depression during withdrawal can still be treated on its own terms by a prescriber where appropriate, and any opioid or alcohol use happening alongside is treated separately.

Does insurance cover detox?

Often, though the policy decides. Federal parity law bars a plan that covers substance use benefits from applying requirements or limits more restrictive than the predominant ones it applies to substantially all medical and surgical benefits. It reaches non-federal governmental plans with more than 50 employees and private employer group plans with more than 50 employees, and individual-market coverage; small-employer plans get the protection through the Affordable Care Act’s essential health benefit requirement instead. Marketplace plans must cover substance use disorder treatment with no annual or lifetime dollar limits.

Sources

  1. National Institute on Drug Abuse. MDMA (Ecstasy/Molly). National Institutes of Health. https://nida.nih.gov/research-topics/mdma-ecstasy-molly
  2. Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 4: Physical Detoxification Services for Withdrawal From Specific Substances. Treatment Improvement Protocol (TIP) Series No. 45, SAMHSA, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64116/
  3. Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 1: Overview, Essential Concepts, and Definitions in Detoxification. Treatment Improvement Protocol (TIP) Series No. 45, SAMHSA, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64119/
  4. National Institute on Drug Abuse. Drugs, Brains, and Behavior: The Science of Addiction — Treatment and Recovery. National Institutes of Health. https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery
  5. Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 2: Settings, Levels of Care, and Patient Placement. Treatment Improvement Protocol (TIP) Series No. 45, SAMHSA, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64109/
  6. National Institute on Drug Abuse. (2012). Principles of Drug Addiction Treatment: A Research-Based Guide, 3rd edition. National Institutes of Health. https://nida.nih.gov/sites/default/files/podat-3rdEd-508.pdf
  7. Centers for Medicare and Medicaid Services. The Mental Health Parity and Addiction Equity Act (MHPAEA). https://www.cms.gov/marketplace/private-health-insurance/mental-health-parity-addiction-equity
  8. HealthCare.gov. Mental Health and Substance Abuse Health Coverage Options. Centers for Medicare and Medicaid Services. https://www.healthcare.gov/coverage/mental-health-substance-abuse-coverage/

This page is for general information and is not medical advice. Only a licensed clinician who knows your history can tell you what is right for you. If you or someone you know is in immediate danger, call 911. For free, confidential support 24/7, call or text 988.

Author
Kevin Wandler
Chief Medical Officer, The Recovery Village

Ready to make a change?

Get cost-effective, quality addiction care that truly works.

Start Your Recovery
We're here to help you or your loved one.
Question mark symbol icon

Who am I calling?

Calls will be answered by a qualified admissions representative with Advanced Recovery Systems (ARS), the owners of DrugRehab.com. We look forward to helping you!

Question mark symbol icon

Who am I calling?

Phone calls to treatment center listings not associated with ARS will go directly to those centers. DrugRehab.com and ARS are not responsible for those calls.

If you are experiencing a medical emergency, call 911. If you are having thoughts of suicide, call or text 988, the Suicide & Crisis Lifeline.